DICE — Dice Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMid Cap
- $2.27bn
- $1.72bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 26.6 | 59.7 | 319 | 574 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 2 | 2 | 2 | 0 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 29.1 | 62.1 | 324 | 578 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 1.93 | 1.66 | 1.65 | 16 |
Other Long Term Assets | ||||
Total Assets | 31.2 | 63.9 | 326 | 594 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 3.71 | 9.29 | 10.9 | 15.1 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 5.11 | 9.63 | 12.8 | 27 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Unrealized Gain / Loss | ||||
Other Equity | ||||
Total Equity | 26.1 | 54.2 | 313 | 567 |
Total Liabilities & Shareholders' Equity | 31.2 | 63.9 | 326 | 594 |
Total Common Shares Outstanding |